Mitochondria are highly integrated organelles that are crucial to cell adaptation and mitigating adverse physiology. Recent studies demonstrate that fundamental signal transduction pathways incorporate mitochondrial substrates into their biological programs. Reversible phosphorylation is emerging as a useful mechanism to modulate mitochondrial function in accordance with cellular changes. Critical serine/threonine protein kinases, such as the c-Jun N-terminal kinase (JNK), protein kinase A (PKA), PTEN-induced kinase-1 (PINK1), and AMP-dependent protein kinase (AMPK), readily translocate to the outer mitochondrial membrane (OMM), the interface of mitochondria-cell communication. OMM protein kinases phosphorylate diverse mitochondrial substrates that have discrete effects on organelle dynamics, protein import, respiratory complex activity, antioxidant capacity, and apoptosis. OMM phosphorylation events can be tempered through the actions of local protein phosphatases, such as mitogen-activated protein kinase phosphatase-1 (MKP-1) and protein phosphatase 2A (PP2A), to regulate the extent and duration of signaling. The central mediators of OMM signal transduction are the scaffold proteins because the relative abundance of these accessory proteins determines the magnitude and duration of a signaling event on the mitochondrial surface, which dictates the biological outcome of a local signal transduction pathway. The concentrations of scaffold proteins, such as A-kinase anchoring proteins (AKAPs) and Sab (or SH3 binding protein 5-SH3BP5), have been shown to influence neuronal survival and vulnerability, respectively, in models of Parkinson's disease (PD), highlighting the importance of OMM signaling to health and disease. Despite recent progress, much remains to be discovered concerning the mechanisms of OMM signaling. Nonetheless, enhancing beneficial OMM signaling events and inhibiting detrimental protein-protein interactions on the mitochondrial surface may represent highly selective approaches to restore mitochondrial health and homeostasis and mitigate organelle dysfunction in conditions such as PD.
| BACKG ROU N D
Mitochondria are highly integrated organelles responsible for regulating cellular bioenergetics and viability in a continually changing environment. This extensive level of integration requires intricate and precise systems for communication with other cellular compartments. As the cellular environment changes, mitochondria must adjust their function, and cells must be able to detect, respond, and modulate mitochondria rapidly to adapt. Mitochondria have evolved sophisticated signaling mechanisms with cells that involve gases, ions, hormones, metabolites, and proteins.
1 Thus, mitochondria are crucial hubs for receiving, integrating, and transmitting signals within cells. 2 Environmental, cellular, and organellebased messengers impact all areas of mitochondrial physiology including genome integrity, bioenergetics, translation, and protein import ( Figure 1 ).
3
The quickness necessitated for accurately adjusting mitochondrial function to physiological perturbations implies that post-translational modifications (PTMs) of local proteins are used before the induction of transcriptional programs. Reversible phosphorylation has emerged as a prominent mechanism for rapidly regulating mitochondrial protein function; in fact, recent proteomic studies indicate that ~40% of the organelle proteome is phosphorylated. [4] [5] [6] [7] [8] Additionally, over 30 protein kinases and phosphatases are reported to migrate to mitochondria or have mitochondrial substrates. 6, [8] [9] [10] [11] These phosphorylation events affect metabolism, mitochondrial dynamics, organelle function, and apoptosis demonstrating the importance of coordinated mitochondria-cell communication.
The outer mitochondrial membrane (OMM) is the interface between mitochondria and the rest of the cell. Despite that most mitochondrial proteins reside within the inner mitochondrial membrane (IMM), the OMM hosts significant elements of mitochondrial physiology including organelle dynamics, protein import, and apoptosis.
Consequently, protein kinases and phosphatases on the OMM are appropriately positioned to convey signals to and from mitochondria to directly manipulate mitochondrial form and function. The importance of OMM signaling is supported by numerous studies demonstrating that cytosolic kinases migrate to the organelle surface and modify local substrates to affect mitochondrial physiology. 8, 9, 11 Neurons have a particular reliance on mitochondria for energy production, calcium buffering, and managing ionic changes related to synaptic transmission. 12 Furthermore, dysfunction of OMM signaling components can contribute to the pathophysiology of neurodegenerative diseases, such as Alzheimer's disease (AD) and
Parkinson's disease (PD). 9, 13 In this review, we will identify the kinases and phosphatases found on the OMM (summarized in Table 1 ) of neurons and other CNS cells.
We will present the molecular architecture required for each signaling protein and discuss the effects of specific substrate phosphorylation events including the impacts on organelle and neuronal physiology.
We will highlight how perturbations in kinase and phosphatase activities can contribute to the pathophysiology of neurological diseases.
F I G U R E 1 Mitochondrial signaling mechanisms regulate organelle, cell, and organisms physiology. Mitochondria are influenced by the intracellular and extracellular stimuli such as ions, metabolites, and molecules in the environment like oxygen and pesticides. However, the impact of signaling cascades in response to indirect actions of second messengers or stressors is emerging as significant manipulators of physiology. Mitochondrial signaling and second messengers have been shown to affect mitochondrial processes ranging from local events such as bioenergetics, mitochondrial dynamics, and proteins import to controlling transcriptional programs such as mitochondrial biogenesis, gene expression, and redox homeostasis. Of course, mitochondria are crucial to cell viability because the organelles are home to cell death machinery. Mitochondrial signaling can also transcend the cell through metabolites, second messengers, and even extracellular vesicles to impact metabolism, immune responses, inter-tissue signaling, and the microbiota within an organism. Mitochondrial signaling has emerged as a critical component to human health and disease. The stimuli and transcriptional programs converge on signaling proteins on the outer mitochondrial membrane (OMM), which are uniquely positioned to receive and convey signals from both cell and organelle. Discrete OMM signaling events then coordinate mitochondrial and cellular responses to adapt organelle, cell, and organismal physiology to the current environment 
| OMM PROTEIN KINA S E S
Protein kinases influence mitochondrial protein function through phosphorylation. Intriguingly, most kinase activity within mitochondria can be attributed to tyrosine kinases such as Src. 14, 15 Alternatively, much of the phosphorylation on the mitochondrial surface is associated with serine/threonine (Ser/Thr) protein kinases. 8 Accordingly, the OMM protein kinases are almost exclusively Ser/Thr kinases, which we will discuss below.
| MITOG EN -AC TIVATED PROTEIN K INA S E S (MAPK S)
MAPKs, namely the c-Jun N-terminal kinase (JNK), extracellular regulated kinase (ERK1/2), and p38, 16 exhibit transient mitochondrial localization in responses to cellular stimuli and stress. The principal targets of mitochondrial MAPKs appear to be the Bcl-2 protein superfamily members, which explains the impact mitochondrial MAPKs have on the regulation of cell death pathways. 16 Recent studies show that JNK, ERK, and p38 can phosphorylate OMM substrates involved in mitochondrial dynamics and bioenergetics.
| c-Jun N-terminal kinase
The most well-characterized MAPK with OMM localization is the c-Jun N-terminal kinase (JNK). There are three JNK isoforms (JNK1, JNK2, and JNK3) that are expressed in the brain, and studies from mice suggest that JNK isoforms account for most of the proline-directed phosphorylation in the brain. 17, 18 The activities of JNKs have been delineated in rodent brains with JNK1 accounting for most of the signaling in the cortex and cerebellum, and JNK3 accounts for the bulk of activity in the hippocampus and striatum. 19, 20 Discrete subcellular may contribute to the diverse JNK substrates and physiological roles of JNK signaling in the brain with nuclear and cytosolic isoforms targeting different substrate pools. The cytosolic JNK species probably become the mitochondrial JNK species based on localization. Also, the functional redundancy and compensatory activities of JNK isoforms indicate that multiple JNKs could contribute to mitochondrial JNK signaling. 18, 21, 22 In cerebral ischemia, researchers propose that JNK1 may be an early mitochondrial effector with JNK3 migrating to mitochondria later and inducing apoptosis. 23 Similarly, in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic (DA) neuron degeneration in mice, ablation of both JNK2 and JNK3 was necessary to protect DA neurons from the neurotoxic insult. 24, 25 These data imply that JNK1 is involved in physiological JNK signaling, while JNK2 and JNK3 are responsible for JNK-mediated apoptosis; meanwhile, these studies highlight the potential for all JNK isoforms to localize on mitochondria.
Mitochondrial JNK signaling is linked to apoptosis in numerous tissues, including the brain, following cytotoxic stress. While the molecular mechanism of JNK translocation to the OMM remains to be determined, the scaffold protein, Sab (or SH3BP5), anchors JNK on mitochondria. [26] [27] [28] Sab is a single-pass transmembrane protein oriented in the OMM with the N terminus of the protein in the mitochondrial intermembrane space and the C terminus on the cytosolic face of the OMM. 29 JNK interacts with Sab through kinase interacting motifs (KIM1/2) near the C terminus of Sab, 26, 28, 30 and ablation of these sites or use of a competitive peptide (Tat-Sab KIM1 ) can prevent JNK translocation to mitochondria. 26, 31, 32 Disrupting the interaction between JNK and Sab is neuroprotective in rodent models of PD and cerebral ischemia. 23, 33 Mitochondrial JNK activity impacts apoptosis, metabolism, and organelle dynamics ( Figure 2) has yet to be determined, JNK translocation to the OMM is linked to enhanced ROS production. The direct inhibition of both PDH and complex I by JNK is problematic given that the substrates are within the mitochondria, and JNK had been shown to be present F I G U R E 2 c-Jun N-terminal kinase (JNK) on the OMM impacts apoptosis and bioenergetics. JNK signaling has long been linked to cell death and metabolism, and only recently was it realized that mitochondrial JNK signaling on the OMM scaffold protein Sab was critical to the induction of apoptosis through the manipulation of proteins within the Bcl-2 superfamily. Following activation, JNK translocates to mitochondria. JNK interacts with and phosphorylates the OMM scaffold protein Sab most likely through an interaction with the KIM2 motif (K2) because the KIM1 motif (K1) may be on the inner leaf of the OMM. In cases of neurotoxin exposure, ischemia, and cytotoxic stress, mitochondrial JNK activity leads to amplification of ROS production, organelle dysfunction, and cell death. Mitochondrial JNK can impair complex I by a yet-to-be-described mechanism to impair mitochondrial metabolism and engage ROS production. However, this may be facilitated by signaling on the coiled-coil motifs (CC1/CC2) of Sab's SH3 domain. Mitochondrial JNK can initiate apoptosis through phosphorylation of Bcl-2 on Ser70 inducing its emigration from mitochondria. JNK activity on mitochondria has also been demonstrated to impact mitochondrial dynamics through phosphorylation of Mfn2, which leads to its degradation and mitochondrial fission. JNK also influences mitochondrial metabolism directly through the inhibition of PDH via phosphorylation of the Eα1 subunit. In addition to Bcl-2, JNK can also influence the activities of BH3-only proteins such as Bim to induce apoptosis, and mitochondrial JNK has been shown to phosphorylate Bax to induce permeabilization of the OMM. The local activities of mitochondrial JNK suggest it could be a significant physiological player in organelle health on the mitochondrial surface. 
| Extracellular regulated kinase
The extracellular regulated kinase (ERK) exists as numerous isoforms in the brain with ERK1/2 being the most well-characterized species of the family. Similar to JNK, ERK1/2 activity on the mitochondria has been reported in the hippocampus, 60 implicated in PD, 61 
| P38 kinases
The p38 kinases, in particular p38α (MAPK14), have been implicated in the pathogenesis of neurodegenerative, and pharmacological inhibitors of p38 have been shown to protect against neuronal loss in preclinical models of neurodegenerative disorders in the CNS. 81, 82 The basis for these studies stems from the involvement of p38 in apoptosis. The general effect of p38 signaling affects the levels of Bcl-2 (decrease) and Bax (increase) levels on mitochondria through transcriptional and post-transcriptional means contributing to potentiating cells toward apoptosis. 83 However, p38 direct effects on Bcl-2 superfamily proteins remain elusive. Nonetheless, p38 has been shown to migrate to mitochondria follow stress (such as ischemia or oxidative stress) in cardiac tissue. 84 Court and colleagues
proposed that p38γ interacts with outer mitochondrial protein 25
(OMP25) that impaired p38γ activity in vitro. 85 To date, mitochondrial p38, specifically p38γ, has been shown to converge on mitochondria and phosphorylate Sab, a well-established mitochondrial scaffold protein for JNK. 86 Investigators demonstrated in vitro p38γ
phosphorylated Sab on Ser321, 86 which is in KIM1, preceding a transmembrane motif. 29 This places Ser321 within the mitochondria, and no documentation of p38 within mitochondria has been made raising questions to the contributions of this PTM to physiological mitochondrial signaling. Regardless, p38 is a significant player in signaling regulating mitochondrial health.
| PROTEIN K INA S E A , G , C ( AG C K INA S E S)
The AGC kinase family has two members present on the OMM that can influence organelle physiology: PKA and isoforms of PKC.
87
PKA is likely the most well-investigated cytosolic kinase on the mitochondrial surface, as it is well documented to play a role in sustaining organelle health. 88 Meanwhile, the role of PKC on mitochondria is more complicated with distinct variants contributing to the divergent aspects and outcomes of mitochondrial function and health.
89,90
| Protein kinase A (PKA)
Mitochondrial PKA has long been associated with mitochondria through its interaction with scaffold proteins of the A-kinase anchoring proteins (AKAP) family in particularly AKAP-1 (or D-AKAP as often used for the mitochondrial PKA scaffold). 91, 92 PKA has been documented to affect numerous mitochondrial proteins ranging from bioenergetics to dynamics to redox homeostasis and cell survival. 93 The substrates for mitochondrial PKA have been identified both on and within mitochondria suggesting the ability of mitochondrial PKA to transcend the OMM. Mitochondrial PKA signaling is thought to be mainly beneficial to the organelle facilitating essential functions such as protein import while impeding processes such as fission and apoptosis. 94 Increasing the levels of mitochondrial PKA through genetic and pharmacological manipulation has been shown to be neuroprotective in preclinical models of neurodegenerative diseases, specifically PD. [95] [96] [97] Furthermore, adding an OMM localization signaling to the N terminus of PKA can diminish the effects of mitochondrial toxins and stress. 95, 96 These protective effects are best represented by the mitochondrial substrates of PKA on the OMM described immediately below and in Figure 3 .
The most recent analysis of PKA with concerning OMM signaling and organelle physiology have involved the molecular machinery of mitochondrial dynamics. 98 Mitochondrial PKA was first linked to organelle dynamics through phosphorylation of Drp-1.
99
PKA phosphorylation of Drp-1 on Ser637 impairs the function of Drp-1 preventing fission, which results in elongated mitochondria.
Ablation of Drp-1 Ser637 or dephosphorylation by calcineurin was found to activate Drp-1 leading to organelle fragmentation.
Increasing mitochondrial PKA was found to also protect neurons from neurotoxin-induced cell death in part through phosphorylation of Drp-1. 95 The manipulation of Drp-1 by PKA could be crucial to maintaining mitochondrial integrity and health and may affect mitochondrial transport in neurons as well as mitochondrial integration at synapses. 96, [100] [101] [102] [103] PKA activity on the OMM has been shown to influence the stability of PTEN-induced kinase-1 (PINK1), 104 which is a crucial component of mitophagy, through the phosphorylation of proteins in the mitochondrial contact site and cristae organizing system (MICOS). import into mitochondria and integration with other complex I subunits. 110 Consequently, mutations that disrupt the NDUFS4 Ser173 phosphorylation site are linked to complex I dysfunction in the mitochondrial encephalomyopathy Leigh syndrome, a neuromuscular disorder associated with impaired mitochondria function. 111, 112 In addition to modification of NDUFS4, mitochondrial PKA also influences the protein stability of complex I by inhibiting intramitochondrial proteases capable of degrading complex I constituents, NDUFA9, NDUFS4, and NDUFV2.
113
Pharmacological inhibition of mitochondrial soluble adenylyl cyclase (sAC) results in the proteolytic degradation of these components due to diminished local PKA activity. 113 Alternatively, complex IV (cytochrome c oxidase) subunits can be directly phosphorylated by mitochondrial PKA, and distinct modifications can serve to modulate complex function. 114 For example, PKA phosphorylation of complex IV subunit I on Ser58 nullifies ATP-dependent inhibition of complex IV sustaining activity, whereas PKA phosphorylation of subunits I, IV-1, and Vb during hypoxia triggers degradation of the proteins and diminishes complex IV activity. 115, 116 Similarly, mitochondrial PKA can modulate complex V activity.
Local PKA phosphorylation of ATPase inhibitory factor 1 (AIF1) on Ser39 prevents the interaction between AIF1 and complex V maintaining ATP synthase activity. 117, 118 Also, decreasing PKA activity in mitochondria can lead to the proteolytic degradation of complex V components resulting in less ATP synthesis. 118, 119 The proximity of PKA to the bioenergetic machinery makes the kinase a useful regulator of ATP production and the ETC Furthermore, the relationship between ATP production and mitochondrial PKA activity extends to signaling transduction pathways. Wherein, activation of the AMPdependent protein kinase (AMPK) can phosphorylate and stabilize D-AKAP to engage ATP production and promote cell survival.
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Mitochondrial PKA can be considered to be a crucial component of ETC and mitochondrial bioenergetic regulation. These results indicate that diminished PKA signaling is a component of neurodegenerative disorders and restoring local PKA activity could be a means to impede the pathogenesis of these conditions.
| Protein kinase C (PKC)
Protein kinase C isoforms are emerging as potential regulators of mitochondrial function in the areas of metabolism and apoptosis [137] [138] [139] ;
however, a complicating factor could be that distinct activities of PKC isoform could have discrete impacts on mitochondrial physiology. To date, three isoforms of PKC, PKCα, 140 PKCδ, and PKCε, 141 have shown mitochondrial localization. PKCδ is associated more with neurodegeneration and neuroinflammation, 142, 143 while PKCε has been demonstrated to be more protective. 144 PKCδ has been shown to undergo cleavage by caspase activity in response to stress, and the cleaved species of PKCδ contributes to stress-induced mitochondrial dysfunction. PKCδ-induced mitochondrial dysfunction is also associated with dopaminergic neurotoxicity in preclinical PD models. 143, 145 Although the outcomes of mitochondrial PKCδ signaling affect apoptosis, respiration, membrane potential, ROS production, antioxidant capacity, and organelle dynamics, [146] [147] [148] only Drp-1 has been shown to interact with PKCδ and contribute to organelle fragmentation. 149 Further investigation is needed to elaborate on PKCδ functions at mitochondria.
PKCε also demonstrates mitochondrial localization in response to cerebral ischemia and increases sirtuin 5 (Sirt5) levels.
150
Outside of this report, most of the work has been performed in non-CNS tissues. PKCε has been shown to phosphorylate complex IV and increase its activity in the heart and kidney in response to stress. 138, 151 Also, PKCε has been shown to phosphorylate and regulate cardiac sodium channels in response to metabolic changes.
Concerning the CNS, PKCε phosphorylation has been shown to increase the activity of endothelin converting enzyme (ECE), which is responsible for amyloid beta clearance, via an N-terminal modification site. 152 This would indicate that PKCε may be downregulated in Alzheimer's disease, 153 and restoring PKCε activity could be neuroprotective similar to how PKCε activity is observed in cardiac tissue.
| PARKIN SON ' S D IS E A S E RELE VANT PROTEIN K INA S E S
Protein kinases have been implicated in the pathogenesis of 
| Leucine-rich repeat kinase 2 (LRRK2)
A protein kinase implicated in familial and sporadic cases of PD is 165 and peroxiredoxin 3 (PRDX3).
166
Early studies found that expression of the most common clinical LRRK2 mutant G2019S could impact mitochondrial morphology increasing mitochondrial fission. The enhanced fission was found to be a result of interaction between LRRK2:G2019S and Drp-1. 160 The recruitment of Drp-1 to mitochondrial and subsequent fission in PD patient-derived fibroblasts and human SH-SY5Y cells was found to be dependent upon LRRK2 kinase activity. 161, 162 Given the recent identification of Rab GTPases, specifically Rab7, 167 as bonafide LRRK2 substrates, 168 it is likely that mutant LRRK2 activity could drive mitochondrial fragmentation observed in PD patients by assembling the protein machinery and activating membrane fusion.
169

LRRK2: G2019S expression in HeLa cells revealed that LRRK2
mutants interacted with and phosphorylated Bcl-2 on Thr56 to increase autophagy and mitochondrial mass. 159 However, Hsieh and colleagues reported that LRRK2 in iPSC-derived neurons facilitate the interaction of damaged mitochondria with the microtubule motor accessory protein Miro paving the way for clearance of depolarized organelles; consequently, LRRK2:G2019S impedes the interaction of Miro with damaged mitochondria slowing the clearance of potentially detrimental organelles from neurons. 164 Additionally, LRRK2:G2019S is linked to aberrant mitochondrial trafficking, specifically axonal transport, through inhibition of the Miro-mitochondrial interaction. 164 Fibroblasts from PD patients do exhibit more mitochondrial fragmentation and enhanced mitophagy initially compared to control cells. Thus, the role of LRRK2 in mitophagy will require a closer examination.
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Lastly, enhanced LRRK2 kinase activity can affect ROS levels and production through manipulation of mitochondrial substrates. 
| PTEN-induced kinase 1 (PINK1)
PTEN-induced putative kinase 1 (PINK1) has drawn significant attention due to its role in mitophagy and association with PD. Under basal conditions, PINK1 is transported into the mitochondrial matrix through the translocases of the outer membrane, TOM20 and TOM23, the translocation channel TOM40, and the translocase of inner membrane TIM23. Inside the mitochondrial matrix, PINK1 is cleaved by a mitochondrial processing peptidase (MPP) and a rhomboid protease, PARL. [170] [171] [172] The cleaved PINK1 is then re-transported into the cytosol and degraded by the ubiquitin (Ub) proteasome system (UPS). The phosphorylated Parkin translocates to the mitochondria and is further activated by the PINK1-phosphorylated Ub. 177 Parkin's subsequent ubiquitination of OMM substrates leads to an enrichment of Ub molecules around the damaged mitochondria that enter a positive feedback cycle through PINK1 phosphorylation.
182
PINK1 can also alter OMM signal transduction to drive fission.
Activation of PINK1 destabilizes the interaction between PKA and anchoring protein AKAP-1, preventing unnecessary mitophagy. 
| OTHER K INA S E S A SSO CIATED WITH OMM
As mentioned earlier, the occurrences of cytosolic protein kinases are increasing and more OMM kinases are being found through disease-specific proteomic studies. These include protein kinases that are implicated in cellular homeostasis, such as AMP-dependent protein kinase (AMPK), casein kinases (CK1 and CK2), and mammalian target of rapamycin (mTOR). Intriguingly, kinases implicated in the cell cycle have also emerged as OMM signaling agents. The appearance of these kinases on the OMM is further evidence of the extensive integration of organelle and cell physiologies and quality control.
| AMP-dependent protein kinase (AMPK)
A recent addition to the OMM signaling landscape is the AMPdependent protein kinase (AMPK), which was identified in two independent reports. 120 
| Cyclin-dependent kinase 11 (Cdk11)
Similar to Cdk5, cyclin-dependent kinase 11 (Cdk11) has been
shown by colocalization studies to have subpopulation on mitochondria. 203, 204 After the identification of Cdk11 on mitochondria, there have been no follow-up studies to identify substrates.
Intriguing the localization of Cdk11 preceded the induction of apoptosis leading investigators to surmise that Cdk11 may have a role in the induction of cell death. 203, 204 Cdk11 represents an interesting OMM kinase for study, as research related to mitochondria. Cdk11 could shed light on the relationship between organelle physiology and the cell cycle.
| Casein kinase I (CK1)
Both casein kinase I and II (CK1 and CK2) have been described to have mitochondrial influence and localization. 124, 205, 206 CK1 and CK2 are commonly viewed as Ser/Thr kinases that influence the activity of transcription factors to influence developmental signaling (ie, Wnt pathway) and circadian rhythms. However, CK1 and CK2 have been implicated in the regulation of mitochondrial function.
CK1 is involved the inhibition of Fas-mediated apoptosis through the phosphorylation of Bid on Ser64 and Ser66. 207, 208 Phosphorylation by CK1 prevents the cleavage of Bid by caspase 8 limiting the release of cytochrome c from mitochondria. 207, 208 While specific CK1 targets on mitochondria have yet to be identified, CK1 has been colocalized with mitochondria, and further studies may unearth CK1
substrates on mitochondria.
| Casein kinase II (CK2)
The role of CK2 on mitochondria is more extensive than CK1
where in addition to apoptosis CK2 plays a significant role in the regulation of organelle protein import 122, 123 and quality control. 206 Concerning apoptosis, CK2 is known to phosphorylate 
| Mammalian target of rapamycin (mTOR)
The mTOR signaling pathway has long been implicated in sensing mitochondrial substrates like branched amino acids; moreover, mTOR has been linked to bioenergetics and mitochondrial protein synthesis for some time. 212, 213 The localization of mTOR signaling components on lysosomes and in proximity to mitochondrial-associated membranes (MAMs) meant it was only a matter of time before mitochondrial mTOR substrates would be discovered. 214 Indeed, mTOR was reported to localize to mitochondria via the OMM protein FKBP38, a member of the FK506-binding protein family. 215 This interaction places mTOR in close to Bcl-2 proteins associated with VDAC1. The number of reported protein kinases localizing to mitochondria continues to grow at an increasing pace. The reports of new signaling kinases on the OMM reflect the structural and functional integration of mitochondria with other subcellular compartments.
Thus, the kinases presented above may only be a modest sampling of the cascades present on the mitochondrial surface.
| OMM PROTEIN PHOS PHATA S E S
Compared to the breadth of studies on OMM protein kinases, far less is known regarding the activities and substrates of protein phosphatases on the mitochondrial surface. Because a number of the phosphorylation events ascribed to protein kinases on the OMM are reversible, it is likely that some phosphatases would be required to offset and regulation these phosphorylation events to adjust and maintain organelle physiology. 8, 11 We will describe the actions of some of the known protein phosphatases on mitochondria below.
| Mitogen-activated protein kinase phosphatase-1 (MKP-1)
MKP-1 is a dual specificity phosphatase capable of dephosphorylating Ser/Thr and Tyr residues modified by protein kinases. 224 As the name implies, the primary substrates of MKP-1 are the MAPKs. As described earlier, MAPKs (namely JNK, ERK1/2, and p38) can translocate to mitochondria and manipulate local proteins. MKP-1 was also found to migrate to neuronal mitochondria in response to treatment of cells with neuronal growth factor. 224, 225 It is proposed that JNK is a substrate of MKP-1 on mitochondria based on brain-related studies [226] [227] [228] suggesting that MKP-1 may act to inactivation JNK signaling to prevent apoptosis. Further investigation is warranted to determine whether the phosphatase affects other MAPKs on mitochondria or has unique substrates on the OMM.
| Phosphate and tensin homolog-long (PTEN-L)
A 
| Protein phosphatase 1 (PP1)
The PP1 is linked to the regulation of local signaling transduction on the OMM and the function of proteins related to apoptosis. [230] [231] [232] [233] PP1 forms a complex with PKA and AKAP1 on the mitochondrial surface, 234 and in the absence of PKA, PP1 can destabilize AKAP1
leading to its degradation and reduce potential sites for mitochondrial PKA signaling. 235 This event was linked to the induction of long-term depression through the dephosphorylation of AMPA receptor. 234 OMM PP1 has been cited as a regulator of p38 signaling on mitochondria as well. PKC was found to induce PP1 following exposure to phorbol ester leading to dephosphorylation and inactivation of p38 on the mitochondria. 231 These studies indicate that PP1 could modulate OMM signaling in a context-dependent fashion.
PP1 is associated with the dephosphorylation of Bcl-2 proteins and the induction of apoptosis. 232 PP1 dephosphorylation of Bad can release the protein from 14-3-3 and permits Bad's interaction with and inhibition of anti-apoptotic Bcl-2 proteins. 128 PP1 interaction with Bcl-2 and Bcl-xL can also impact phosphatase activity. 236 These results indicate PP1 on the OMM is a regulator of apoptotic proteins. 
| Protein phosphatase 2A (PP2A)
| OMM SC AFFOLD PROTEIN S
Scaffold proteins and adaptor proteins are crucial accessory proteins required for the coordination of signal transduction events across space and time. 240, 241 The relative abundance of accessory proteins can dictate the biological outcomes of signaling events by influencing the spatial magnitude and duration of a response. 240, 241 Therefore, the identification and concentrations of these elements of molecular architecture will be critical to determine the presence and impact of signaling pathways on mitochondria.
| A-kinase anchoring protein 1 (AKAP-1)
AKAPs are membrane-bound scaffolds for PKA and its related signaling components. 
| Sab (SH3-binding protein 5; SH3BP5)
As mentioned above, Sab is an OMM scaffold for the JNK and a putative substrate of p38γ on the OMM. 27, 28 To date, no other outer membrane kinases have been shown to interact with Sab. This could be due to the topology of Sab, which may make it selective for MAPKs on the OMM. Near the C terminus of Sab, there are two kinase interacting motifs (KIM1 and KIM2) (see Figure 2) Recent studies from our laboratory demonstrate that increasing Sab levels in mitochondria renders cells vulnerable to stresses due to elevated levels of JNK signaling on the OMM. Demonstrating that the relative levels on scaffold proteins on the OMM dictate signaling outcomes, and the collective levels of distinct scaffolds could indicate how mitochondria may respond to cellular cues and stresses.
We have found that Sab mRNA and protein levels are significantly enriched in the hippocampus, substantia nigra, and cerebellum, areas of the brain vulnerable to neurotoxin stimuli. 251 Thus, we contend that the elevated Sab concentrations could lead to robust mitochondrial JNK activity contributing to apoptosis and neurodegeneration in disorders such as AD and PD. Selective disruption of the JNK-Sab interaction protects dopaminergic neurons from 6-hydroxydopamine-induced neurotoxicity. 33 Thus, the specific targeting of detrimental mitochondrial JNK signaling could be a promising target to preserve mitochondrial health in PD.
| Protein interacting with C-kinase-1 (PICK1)
PICK1 is a scaffold protein for PKCs, and PICK1 has been linked to PKAα localization on mitochondria, where the kinase protected against apoptosis induced by genotoxic stress. [252] [253] [254] Another report indicates that PICK1 on mitochondria can impair Parkin activity and contribute to MPTP-induced neurotoxicity. PICK1 destabilized the interaction between Parkin and UbcH7 leading to diminished E3 ubiquitin ligase activity of Parkin. PICK1 knockout mice were protected against MPTP-induced cell death. 255 This effect of PICK1 is interesting in light of the neurotoxic and neuroinflammatory activities of PKCδ and may be another mechanism by which shifts in OMM signaling can contribute to PD pathogenesis and progression.
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Additional scaffold proteins may also be localized to the OMM, as reports indicate that 14-3-3 may have a population of mitochondrial proteins that influence organelle signaling. 257, 258 Also, the growth factor receptor-bound protein 10 (Grb10) may have OMM localization. 259 We contend that the accurate and reliable identification of OMM scaffold proteins will be crucial to determining the localization and signaling pathways to the mitochondrial surface.
| CON CLUD ING REMARK S AND FUTURE DIREC TIONS
In this review, we have presented some of the emerging signaling cascades and phosphorylation events on the mitochondria surface.
OMM signaling components are appropriately positioned to impact specific aspects of mitochondrial physiology. It is likely that more rigorous studies in this area will unearth more kinases, phosphatases, and adaptor proteins. Great care should be taken in identification and validation of new signaling components on the OMM using established as well as modern proteomic-based approaches.
While the identification of OMM signaling components and signaling cascades continues to be of interest, many of the OMM kinases are beginning to demonstrate interplay on the organelle surface. Earlier, we mentioned that AMPK could stabilize PKA signaling on mitochondria to enhance ETC function. 120 However, antagonism by kinases may also occur. The best current evidence for this is that PINK1 can impair the kinase activity of LRRK2, [260] [261] [262] an effect which is lost in iPSC-derived neurons from PD patients harboring PINK1 mutations. Similarly, overexpression of Parkin can prevent dopaminergic neuron loss in the presence of LRRK2:G2019S. 260, 261 In addition to modulating protein function, it is likely that signaling cascades can target opposing pathways for degradation using by manipulating local E3-ubiquitin ligases or other turnover mechanisms (ie, autophagy). But, one can anticipate that the scaffolding and organization of these molecular pathways will be critical to this integration. This potential has been noted with AKAP1, which plays a crucial role in the integration of PKA and mTOR signaling modules. 217 It is likely that similar mechanisms exist for other signaling proteins to balance mitochondrial form and function in an everchanging cellular environment. Research oriented around these distinct interactions will be critical to understanding the complex regulation of mitochondrial function and dysfunction in disease pathogenesis, and this scenario also highlights the need to consider therapeutic regimens that impair detrimental events while restoring beneficial signaling pathways on the OMM.
It is likely that the OMM signaling pathways will be highly responsive to mitochondrial messengers, such as ROS, and OMM proteins are appropriately positioned to recognize and response to these small molecules. The response to these messengers will shape cellular responses to the organelle health status. An example of this type of integration may be best illustrated by the interplay between ROS and the members of the Bcl-2 superfamily that dictate apoptotic responses. 263 For example, Bcl-2 can "sense" the magnitude of ROS production in response to post-translational modifications, namely Ser70 phosphorylation, 264 and changes in Bcl-2 can then impact ETC function, mitochondrial antioxidant capacity, and autophagic flux. 263 The robustness of the Bcl-2 response to ROS levels can determine whether a cell undergoes apoptosis. Our work demonstrates that enhancing mitochondrial JNK signaling by increasing Sab levels amplifies ROS production and renders cells sensitive to chemical insults in part by diminishing OMM Bcl-2 levels. 31, 32, 250 It is established that mitochondrial ROS can trigger ASK-1 to engage sustained JNK activity 265 leading to depletion of OMM Bcl-2 by Ser70 phosphorylation and induction of apoptosis. 26 In addition to JNK, numerous OMM localized kinases and phosphatases can modulate Bcl-2 superfamily protein function, which we contend is one significant route to coordinating organelle and cellular physiology because of the importance of Bcl-2 proteins to metabolism, autophagy, and apoptosis. The actions of OMM signaling proteins in response to ROS could dictate the actions of Bcl-2 proteins within the cell. Thus, it is imperative that OMM signaling pathways converging on Bcl-2 proteins be considered with great respect toward cellular environment.
In conclusion, the signalosomes of the OMM are the gatekeepers of mitochondrial physiology and mediators of disease pathogenesis in the CNS, as such there is much promise in the elucidation of signaling relationships on the mitochondrial surface and targeting distinct OMM signaling components to combat CNS disorders.
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